Ryman Healthcare(DE:RH7)
€0.84+0.01 (+2.56%)
DE:RH7
Ryman Healthcare financials statements
€0.84
At close:+0.01 (+2.56%)
Ryman Healthcare (RH7) Ratios
0 Followers
Ryman Healthcare Ratios
DE:RH7's free cash flow for Q4 2026 was NZ$126.60M. For the 2026 fiscal year, DE:RH7's free cash flow was decreased by NZ$-28.96M and operating cash flow was NZ$155.56M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.55 | 0.24 | 2.21 | 3.04 | 2.44 |
| Quick Ratio | 0.55 | 0.24 | 2.20 | 2.98 | 2.35 |
| Cash Ratio | 0.03 | 0.02 | 0.11 | 0.11 | 0.09 |
| Solvency Ratio | -0.02 | -0.05 | 0.01 | 0.04 | 0.10 |
| Operating Cash Flow Ratio | 1.01 | 0.46 | 1.76 | 2.12 | 1.76 |
| Short-Term Operating Cash Flow Coverage | 2.14 | 0.00 | 0.00 | 4.62 | 0.00 |
| Net Current Asset Value | NZ$ -8.01B | NZ$ -7.59B | NZ$ -7.84B | NZ$ -7.07B | NZ$ -6.79B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.14 | 0.20 | 0.19 | 0.24 |
| Debt-to-Equity Ratio | 0.39 | 0.40 | 0.58 | 0.50 | 0.75 |
| Debt-to-Capital Ratio | 0.28 | 0.28 | 0.37 | 0.33 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.28 | 0.37 | 0.32 | 0.43 |
| Financial Leverage Ratio | 3.01 | 2.83 | 2.96 | 2.68 | 3.19 |
| Debt Service Coverage Ratio | 0.12 | -1.78 | 1.96 | 2.14 | 24.75 |
| Interest Coverage Ratio | -0.15 | -0.85 | -1.38 | -0.16 | 0.06 |
| Debt to Market Cap | 0.73 | 0.86 | 0.66 | 0.83 | 0.52 |
| Interest Debt Per Share | 1.68 | 2.58 | 3.81 | 4.77 | 4.94 |
| Net Debt to EBITDA | 63.82 | -61.78 | -49.82 | 5.06 | 3.25 |
| Profitability Margins | |||||
| Gross Profit Margin | -2.22% | 100.00% | -0.21% | -3.53% | 0.36% |
| EBIT Margin | -2.22% | -10.59% | -14.53% | 73.45% | 149.39% |
| EBITDA Margin | 3.10% | -3.80% | -7.80% | 81.77% | 156.47% |
| Operating Profit Margin | -2.22% | -16.57% | -10.70% | -3.53% | 0.36% |
| Pretax Profit Margin | -22.24% | -30.18% | -22.28% | 36.81% | 143.34% |
| Net Profit Margin | -21.46% | -61.20% | 0.73% | 46.03% | 137.54% |
| Continuous Operations Profit Margin | -21.46% | -61.20% | 0.73% | 46.03% | 137.54% |
| Net Income Per EBT | 96.47% | 202.81% | -3.29% | 125.04% | 95.95% |
| EBT Per EBIT | 999.96% | 182.14% | 208.20% | -1043.19% | 39631.28% |
| Return on Assets (ROA) | -1.40% | -3.62% | 0.04% | 2.06% | 6.32% |
| Return on Equity (ROE) | -4.20% | -10.25% | 0.11% | 5.53% | 20.17% |
| Return on Capital Employed (ROCE) | -0.15% | -1.06% | -0.55% | -0.16% | 0.02% |
| Return on Invested Capital (ROIC) | -0.14% | -1.06% | 0.02% | -0.16% | 0.02% |
| Return on Tangible Assets | -1.40% | -3.63% | 0.04% | 2.08% | 6.35% |
| Earnings Yield | -7.96% | -22.29% | 0.12% | 9.19% | 14.09% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.83 | 5.05 | 0.94 | 0.78 | 0.73 |
| Payables Turnover | 11.31 | 9.40 | 5.55 | 5.35 | 6.36 |
| Inventory Turnover | 68020.58 | 61504.15 | 273.21 | 39.67 | 19.08 |
| Fixed Asset Turnover | 0.73 | 0.70 | 0.34 | 0.25 | 0.24 |
| Asset Turnover | 0.07 | 0.06 | 0.05 | 0.04 | 0.05 |
| Working Capital Turnover Ratio | -1.96 | -16.52 | 1.34 | 1.17 | 1.12 |
| Cash Conversion Cycle | 43.27 | 33.47 | 325.25 | 409.61 | 459.41 |
| Days of Sales Outstanding | 75.55 | 72.31 | 389.71 | 468.62 | 497.68 |
| Days of Inventory Outstanding | 0.01 | 0.01 | 1.34 | 9.20 | 19.13 |
| Days of Payables Outstanding | 32.29 | 38.84 | 65.79 | 68.21 | 57.41 |
| Operating Cycle | 75.55 | 72.32 | 391.04 | 477.82 | 516.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.31 | 0.58 | 0.96 | 1.05 | 1.01 |
| Free Cash Flow Per Share | 0.27 | 0.43 | 0.71 | 0.42 | 0.45 |
| Dividend Paid and CapEx Coverage Ratio | 6.76 | 3.82 | 3.82 | 1.38 | 1.31 |
| Capital Expenditure Coverage Ratio | 6.76 | 3.82 | 3.82 | 1.67 | 1.79 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.24 | 0.26 | 0.23 | 0.21 |
| Operating Cash Flow to Sales Ratio | 0.40 | 0.57 | 1.01 | 0.97 | 1.06 |
| Free Cash Flow Yield | 12.65% | 15.45% | 12.57% | 7.79% | 4.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.47 | -4.45 | 810.00 | 10.88 | 7.10 |
| Price-to-Sales (P/S) Ratio | 2.70 | 2.75 | 5.95 | 5.01 | 9.76 |
| Price-to-Book (P/B) Ratio | 0.53 | 0.46 | 0.88 | 0.60 | 1.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.91 | 6.47 | 7.95 | 12.84 | 20.72 |
| Price-to-Operating Cash Flow Ratio | 6.74 | 4.78 | 5.87 | 5.17 | 9.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.17 | 0.00 | -8.21 | -0.18 | 0.11 |
| Enterprise Value Multiple | 150.68 | -133.96 | -126.06 | 11.18 | 9.49 |
| Enterprise Value | 3.74B | 3.64B | 6.40B | 5.12B | 7.48B |
| EV to EBITDA | 150.68 | -133.96 | -126.06 | 11.18 | 9.49 |
| EV to Sales | 4.68 | 5.10 | 9.83 | 9.15 | 14.85 |
| EV to Free Cash Flow | 13.71 | 12.01 | 13.15 | 23.44 | 31.52 |
| EV to Operating Cash Flow | 11.69 | 8.87 | 9.71 | 9.44 | 13.96 |
| Tangible Book Value Per Share | 4.00 | 5.98 | 6.30 | 8.87 | 6.38 |
| Shareholders’ Equity Per Share | 4.01 | 6.00 | 6.42 | 9.03 | 6.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | -1.03 | 1.03 | -0.25 | 0.04 |
| Revenue Per Share | 0.79 | 1.01 | 0.95 | 1.08 | 0.95 |
| Net Income Per Share | -0.17 | -0.62 | 0.01 | 0.50 | 1.31 |
| Tax Burden | 0.96 | 2.03 | -0.03 | 1.25 | 0.96 |
| Interest Burden | 10.00 | 2.85 | 1.53 | 0.50 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 |
| SG&A to Revenue | 0.00 | 0.76 | 0.64 | 0.32 | 0.61 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.87 | -0.80 | 0.00 | 2.11 | 0.77 |
Currency in NZD
